Consensus Conference to Assess Adjuvant Therapy for Breast Cancer
BETHESDA, Md-The National Institutes of Health will convene a consensus development conference on adjuvant therapy for breast cancer on November 1–3, 2000.
BETHESDA, MdThe National Institutes of Health will convene a consensus development conference on adjuvant therapy for breast cancer on November 13, 2000.
The meeting will consider new information on chemotherapy, hormonal therapy, and other treatment aspects, including the clinical use of prognostic markers and quality-of-life issues. A panel of experts from outside NIH will make recommendations after hearing 2 days of presentations by leading researchers. The last breast cancer consensus conference on adjuvent therapy was in 1990.
Articles in this issue
IL-13 Used to Deliver Bacterial Toxin to Brain Tumors in Mice
BAG-1 Overexpression Has a ‘Paradoxical’ Association With Improved Breast Cancer Survival
Rituximab/CHOP Combo Effective in Low-Grade NHL
3D CT-Guided Seminal Vesicle Biopsy for Staging
Elderly Patients Tolerate Breast Cancer Therapy
Coaxial Breast Biopsy Device Provides Diagnostic Specimens
3D Digital Camera Accurately Calculates Breast Shape, Volume
Thermoacoustic CT Under Development for Breast Imaging
Early Local Recurrence After Lumpectomy Predicts Metastasis
Panel Recommends Listing 9 Substances in Carcinogen Report
State of the Union on Youth Smoking ‘Clearly Not Good’
Low-Dose CT Screening Detects NSCLC: ELCAP Update
Mandatory HIV Testing of Newborns Not Routine: HHS
ASCO Launches Large-Scale Study on Quality of Cancer Care
Advocate Urges Greater Attention to Cancer Prevention Research
Recent Videos
Related Content
